METHOD OF 5-CHLORO-7-IODO-8-HYDROXYQUINOLINE'S PHARMACEUTICALLY PURE ZINC COMPLEX PREPARATION

The invention refers to a novel pharmaceutical composition having especially antimycotic activity and comprising the zinc complex of 5-chloro-7-iodo-8-hydroxyquinoline of formula (I) (I) and one or more pharmaceutically acceptable carriers. The pharmaceutical composition of the invention can be used...

Full description

Saved in:
Bibliographic Details
Main Authors KOVACS MARTA DR.,HU, EGRI JANOS,HU, GORGENYI FRIGYES DR.,HU, FEKETE MARTON DR.,HU, MIHOLICS GIZELLA DR.,HU, SZELI MARIA,HU, SEBESTYEN GYULA DR.,HU, SIMONYI ISTVAN DR.,HU, VAGO PAL DR.,HU, SERES ISTVAN,HU
Format Patent
LanguageEnglish
Published 14.04.1989
Edition4
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention refers to a novel pharmaceutical composition having especially antimycotic activity and comprising the zinc complex of 5-chloro-7-iodo-8-hydroxyquinoline of formula (I) (I) and one or more pharmaceutically acceptable carriers. The pharmaceutical composition of the invention can be used for the effective treatment of mycotic infections on the skin surface, mucous membranes or nails. The complex of formula (I) is prepared by reacting a solution of an alkali metal salt of 5-chloro-7-iodo-8-hydroxyquinoline with a solution containing an excess of an inorganic or organic zinc salt or a zinc complex having a lower stability constant than that of the complex of formula (I) and separating the product precipitated.
Bibliography:Application Number: CS19870002035